A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects

Clinical trial NCT07181694 · COMPLETED

Trial details

NCT number: NCT07181694
Sponsor: Biocad
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Male

Start date: 2025-03-12
Primary completion: 2026-02-12
Enrollment: 444

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.